Semler Scientific, Inc. (SMLR)
Market Cap | 231.41M |
Revenue (ttm) | 65.88M |
Net Income (ttm) | 21.69M |
Shares Out | 7.07M |
EPS (ttm) | 2.78 |
PE Ratio | 11.78 |
Forward PE | 20.71 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 425,567 |
Open | 33.91 |
Previous Close | 33.74 |
Day's Range | 31.33 - 33.91 |
52-Week Range | 20.88 - 53.38 |
Beta | 0.96 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Aug 8, 2024 |
About SMLR
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, ... [Read more]
Financial Performance
In 2023, SMLR's revenue was $68.18 million, an increase of 20.28% compared to the previous year's $56.69 million. Earnings were $20.58 million, an increase of 43.69%.
Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/p/2/press3-2467380.jpg)
Semler Scientific® Announces Additional Bitcoin Purchases
SANTA CLARA, Calif. , June 6, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chro...
![](https://cdn.snapi.dev/images/v1/e/r/press12-2449821.jpg)
Semler Scientific® Announces Bitcoin Treasury Strategy
SANTA CLARA, Calif. , May 28, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chro...
![](https://cdn.snapi.dev/images/v1/c/v/press9-2416030.jpg)
Semler Scientific® Reports First Quarter 2024 Financial Results
2024 Q1 highlights compared to the corresponding period of 2023: First quarter revenues were $15.9 million, a decrease of 13% First quarter net income was $6.1 million, an increase of 22% Cash, cash e...
![](https://cdn.snapi.dev/images/v1/n/h/conf15-2385215.jpg)
Semler Scientific to Report First Quarter Financial Results and Host Conference Call on May 7, 2024
SANTA CLARA, Calif. , April 23, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in e...
![](https://cdn.snapi.dev/images/v1/6/h/press8-2309574.jpg)
Semler Scientific Reports Fourth Quarter and Full Year 2023 Financial Results
2023 Q4 and full year highlights compared to the corresponding period of 2022: Fourth quarter revenues were $15.1 million, an increase of 9% Fourth quarter net income was $4.2 million, an increase of ...
![](https://cdn.snapi.dev/images/v1/y/u/conf6-2285771.jpg)
Semler Scientific to Report Fourth Quarter and Year End 2023 Financial Results and Host Conference Call on March 5, 2024
SANTA CLARA, Calif. , Feb. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...
![](https://cdn.snapi.dev/images/v1/z/r/press5-2150983.jpg)
Semler Scientific Reports Third Quarter and Year-to-Date 2023 Financial Results
2023 Q3 highlights: Revenue of $16.3 million, an increase of 16% compared to the corresponding period of 2022 Net income of $5.5 million, an increase of 50% compared to the corresponding period of 202...
![](https://cdn.snapi.dev/images/v1/z/s/conf4-2124145.jpg)
Semler Scientific to Report Third Quarter and First Nine Months of 2023 Financial Results and Host Conference Call on November 9, 2023
SANTA CLARA, Calif. , Oct. 26, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...
![](https://cdn.snapi.dev/images/v1/j/q/conf2-2045767.jpg)
Semler Scientific to Present at Upcoming Investor Conference
SANTA CLARA, Calif. , Aug. 31, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...
![](https://cdn.snapi.dev/images/v1/g/i/press12-2018354.jpg)
Semler Scientific Reports Second Quarter and First Half of 2023 Financial Results
2023 Q2 highlights: Revenue was $18.6 million, an increase of 25% compared to the corresponding period of 2022 Net income was $5.9 million, an increase of 44% compared to the corresponding period of 2...
![](https://cdn.snapi.dev/images/v1/d/t/conf3-1994390.jpg)
Semler to Report Second Quarter 2023 Financial Results and Host Conference Call on August 10, 2023
SANTA CLARA, Calif. , July 28, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...
![](https://cdn.snapi.dev/images/v1/q/i/press14-1965784.jpg)
Semler Scientific Announces Appointment of Chief Financial Officer, Record Quarterly Revenues and Strategic Streamlining
SANTA CLARA, Calif. , July 11, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...
![](https://cdn.snapi.dev/images/v1/j/k/press3-1946423.jpg)
Semler Scientific to Join the Russell 2000® and 3000® Indexes
SANTA CLARA, Calif. , June 23, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev...
![](https://cdn.snapi.dev/images/v1/t/l/press3-1883490.jpg)
Semler Scientific Reports First Quarter 2023 Financial Results
2023 Q1 highlights: Revenue was $18.2 million, an increase of 30% compared to the corresponding period of 2022 Net income was $5.0 million, an increase of 48% compared to the corresponding period of 2...
![](https://cdn.snapi.dev/images/v1/j/a/conf18-1864014.jpg)
Semler to Report First Quarter 2023 Financial Results and Host Conference Call on May 10, 2023
SANTA CLARA, Calif. , May 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcar...
![](https://cdn.snapi.dev/images/v1/a/r/press4-1861547.jpg)
Semler Scientific Names Doug Murphy-Chutorian, M.D. as Interim CEO
SANTA CLARA, Calif. , April 28, 2023 /PRNewswire/ -- The board of directors of Semler Scientific, Inc. (Nasdaq: SMLR), is pleased to announce that it has appointed Doug Murphy-Chutorian, M.D.
![](https://cdn.snapi.dev/images/v1/1/k/press20-1844566.jpg)
Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors
Eric Semler Appointed as Chairman SANTA CLARA, Calif. , April 19, 2023 /PRNewswire/ -- - Semler Scientific, Inc. (Nasdaq: SMLR) today announced that Eric Semler and William H.C.
![](https://cdn.snapi.dev/images/v1/i/n/press11-1826499.jpg)
Semler Scientific to Participate in the 22nd Annual Needham Virtual Healthcare Conference
SANTA CLARA, Calif. , April 5, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...
![](https://cdn.snapi.dev/images/v1/6/p/press5-1822912.jpg)
Semler Scientific Comments on CMS Risk Adjustment Changes in the 2024 Medicare Advantage and Part D Final Rate Announcement
SANTA CLARA, Calif. , April 3, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...
![](https://cdn.snapi.dev/images/v1/y/l/press17-1806803.jpg)
Semler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results
2022 Q4 and Full Year highlights compared to the corresponding period of 2021: Fourth quarter revenue was $13.8 million, an increase of 20% Fourth quarter net income was $3.2 million, an increase of 1...
![](https://cdn.snapi.dev/images/v1/y/i/press12-1806798.jpg)
Semler Scientific Names Wayne T. Pan, M.D., Ph.D.
SANTA CLARA, Calif. , March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of health...
![](https://cdn.snapi.dev/images/v1/g/4/press19-1778033.jpg)
Semler Announces Clinical Study Published Using QuantaFlo® as an Aid for Diagnosis of Heart Dysfunction in the Primary Care Setting
SANTA CLARA, Calif. , March 1, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...
![](https://cdn.snapi.dev/images/v1/l/p/press14-1674960.jpg)
Major Clinical Study Using Semler's QuantaFlo® for Medicare Advantage Beneficiaries, Demonstrates that National, In-Home Screening for Peripheral Artery Disease (PAD) is Feasible
SANTA CLARA, Calif. , Dec. 14, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...
![](https://cdn.snapi.dev/images/v1/e/g/press13-1671519.jpg)
Semler Announces Investment in Monarch Medical Technologies
SANTA CLARA, Calif. , Dec. 12, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthc...
![](https://cdn.snapi.dev/images/v1/u/s/press14-1611585.jpg)
Semler Reports Third Quarter and Year-to-Date 2022 Financial Results
2022 Q3 quarterly HIGHLIGHTS compared to the corresponding period of 2021: Revenue was $14.0 million, same as the prior year period Net income was $3.7 million, or $0.55 per basic share and $0.46 per ...